Showing results (401-410 of 440) with videos related to

Sort By:
Pageof 44
Circulation|March 3, 2010
Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathyDavide Gianni, Airong Li, Giuseppina Tesco, et al.
Blood Advances|January 4, 2018
Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesJohn A Snowden, Manuela Badoglio, Myriam Labopin, et al.
Internal Medicine Journal|March 6, 2023
Long-term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysisRichard Blennerhassett, Jad Othman, Amber Biscoe, et al.
The Lancet. Infectious Diseases|May 4, 2013
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trialC Orla Morrissey, Sharon C-A Chen, Tania C Sorrell, et al.
BMC Structural Biology|September 22, 2012
Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitorMaria A Argiriadi, Eric R Goedken, David Banach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2020
Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)Daniel D Murray, John Zaunders, Samuel T Milliken, et al.
Immunity|November 17, 2021
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerabilityDeborah L Burnett, Katherine J L Jackson, David B Langley, et al.
Microbiology Spectrum|September 12, 2022
Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic FibrosisCatherine R Armbruster, Kelvin Li, Megan R Kiedrowski, et al.
Blood|June 21, 2012
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Harry J Iland, Ken Bradstock, Shane G Supple, et al.
The Lancet. Haematology|December 22, 2015
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialHarry J Iland, Marnie Collins, Ken Bradstock, et al.
Pageof 44